Preoperative Serum High-Density Lipoprotein Cholesterol Serves as a Prognostic Marker for Postoperative Prognosis of Distal Cholangiocarcinoma
- PMID: 41168122
- DOI: 10.1002/jhbp.70022
Preoperative Serum High-Density Lipoprotein Cholesterol Serves as a Prognostic Marker for Postoperative Prognosis of Distal Cholangiocarcinoma
Abstract
Background: Researches revealed a close correlation between serum lipid and tumor prognosis. The current study aimed to explore the predictive value of preoperative serum lipid levels for the postoperative prognosis of distal cholangiocarcinoma (dCCA).
Methods: This study retrospectively included 203 dCCA patients who underwent radical surgery in our department. The Kaplan-Meier method and Cox regression model were used for univariate and multivariate analysis. Six machine-learning models were used to build a prediction model for postoperative prognosis. Subgroup and correlation analyses were conducted to reveal influencing factors.
Results: Preoperative high-density lipoprotein cholesterol (HDL-c) had the best area under the ROC curve with a cutoff value of 0.415 mmol/L. Overall survival and disease-free survival were significantly lower in the low HDL-c group (p < 0.05). Univariate and multivariate analyses identified HDL-c ≤ 0.415 mmol/L as an independent risk factor for postoperative tumor recurrence and overall survival. The survival prediction model incorporating HDL-c constructed by the random forest model exhibited optimal prediction value. Subgroup analysis confirmed HDL-c ≤ 0.415 mmol/L as an independent risk factor for postoperative tumor recurrence and overall survival in patients with tumor infiltration depth ≥ 12 mm, lymph node metastasis and elevated preoperative CA19-9.
Conclusion: HDL-c ≤ 0.415 mmol/L is an independent risk factor for postoperative prognosis in dCCA patients.
Keywords: distal cholangiocarcinoma; high density lipoprotein cholesterol; postoperative prognosis; prognostic value.
© 2025 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.
References
-
- Y. Zhu, G. Zu, D. Wu, et al., “Comparison of Laparoscopic and Open Pancreaticoduodenectomy for the Treatment of Distal Cholangiocarcinoma: A Propensity Score Matching Analysis,” Frontiers in Oncology 12 (2022): 1057337.
-
- H. Nazih and J. M. Bard, “Cholesterol, Oxysterols and LXRs in Breast Cancer Pathophysiology,” International Journal of Molecular Sciences 21, no. 4 (2020): 1356.
-
- K. Kawabata, T. Takahashi, K. Tanaka, et al., “Lipolysis‐Stimulated Lipoprotein Receptor Promote Lipid Uptake and Fatty Acid Oxidation in Gastric Cancer,” Gastric Cancer 27, no. 6 (2024): 1258–1272.
-
- D. G. M. Ruiz, F. Biancaniello, F. Gonzalez‐Romero, et al., “Cholangiocarcinoma Progression Depends on the Uptake and Metabolization of Extracellular Lipids,” Hepatology 76, no. 6 (2022): 1617–1633.
-
- S. Fan, Y. Mao, Y. Ge, and Z. Liang, “Association of Preoperative Elevated Lipoprotein (a) With Poor Survival in Patients With Biliary Tract Cancers,” Cancer Medicine 13, no. 11 (2024): e7331.
Grants and funding
LinkOut - more resources
Full Text Sources
